Alto Neuroscience Statistics
Total Valuation
ANRO has a market cap or net worth of $71.20 million. The enterprise value is -$63.12 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANRO has 27.07 million shares outstanding. The number of shares has increased by 274.08% in one year.
| Current Share Class | 27.07M |
| Shares Outstanding | 27.07M |
| Shares Change (YoY) | +274.08% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 56.88% |
| Float | 17.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.53, with a Debt / Equity ratio of 0.19.
| Current Ratio | 22.53 |
| Quick Ratio | 22.15 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.96 |
Financial Efficiency
Return on equity (ROE) is -38.04% and return on invested capital (ROIC) is -23.70%.
| Return on Equity (ROE) | -38.04% |
| Return on Assets (ROA) | -22.88% |
| Return on Invested Capital (ROIC) | -23.70% |
| Return on Capital Employed (ROCE) | -42.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$831,355 |
| Employee Count | 76 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.01% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 5.56 |
| Relative Strength Index (RSI) | 52.40 |
| Average Volume (20 Days) | 241,793 |
Short Selling Information
The latest short interest is 3.01 million, so 11.11% of the outstanding shares have been sold short.
| Short Interest | 3.01M |
| Short Previous Month | 3.27M |
| Short % of Shares Out | 11.11% |
| Short % of Float | 16.80% |
| Short Ratio (days to cover) | 15.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -69.90M |
| Pretax Income | n/a |
| Net Income | -63.18M |
| EBITDA | -69.32M |
| EBIT | -69.90M |
| Earnings Per Share (EPS) | -$2.34 |
Full Income StatementBalance Sheet
The company has $160.75 million in cash and $26.44 million in debt, giving a net cash position of $134.32 million or $4.96 per share.
| Cash & Cash Equivalents | 160.75M |
| Total Debt | 26.44M |
| Net Cash | 134.32M |
| Net Cash Per Share | $4.96 |
| Equity (Book Value) | 139.10M |
| Book Value Per Share | 5.14 |
| Working Capital | 156.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.00 million and capital expenditures -$1.88 million, giving a free cash flow of -$54.87 million.
| Operating Cash Flow | -53.00M |
| Capital Expenditures | -1.88M |
| Free Cash Flow | -54.87M |
| FCF Per Share | -$2.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |